"Technetium Compounds" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Inorganic compounds that contain TECHNETIUM as an integral part of the molecule. Technetium 99m (m=metastable) is an isotope of technetium that has a half-life of about 6 hours. Technetium 99, which has a half-life of 210,000 years, is a decay product of technetium 99m.
| Descriptor ID |
D017556
|
| MeSH Number(s) |
D01.925
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Technetium Compounds".
Below are MeSH descriptors whose meaning is more specific than "Technetium Compounds".
This graph shows the total number of publications written about "Technetium Compounds" by people in this website by year, and whether "Technetium Compounds" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 2001 | 2 | 0 | 2 |
| 2009 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Technetium Compounds" by people in Profiles.
-
Liu G, Dou S, Liang M, Chen X, Rusckowski M, Hnatowich DJ. The ratio of maximum percent tumour accumulations of the pretargeting agent and the radiolabelled effector is independent of tumour size. Eur J Cancer. 2009 Nov; 45(17):3098-103.
-
Liu G, Cheng D, Dou S, Chen X, Liang M, Pretorius PH, Rusckowski M, Hnatowich DJ. Replacing 99mTc with 111In improves MORF/cMORF pretargeting by reducing intestinal accumulation. Mol Imaging Biol. 2009 Sep-Oct; 11(5):303-7.
-
Liu G, Zhang C, Liu F, Wang R, Fu Z, Li G, Miao Z. 99mTc-N, N'-bis(aminoethyl)propanediamine hexaacetic acid (BPHA): a glomerular filtration agent similar to 99mTc-DTPA. Nucl Med Biol. 2002 May; 29(4):399-404.
-
Zhu Z, Wang Y, Zhang Y, Liu G, Liu N, Rusckowski M, Hnatowich DJ. A novel and simplified route to the synthesis of N3S chelators for 99mTc labeling. Nucl Med Biol. 2001 Aug; 28(6):703-8.
-
Qu T, Wang Y, Zhu Z, Rusckowski M, Hnatowich DJ. Different chelators and different peptides together influence the in vitro and mouse in vivo properties of 99Tcm. Nucl Med Commun. 2001 Feb; 22(2):203-15.
-
King MA, Xia W, deVries DJ, Pan TS, Villegas BJ, Dahlberg S, Tsui BM, Ljungberg MH, Morgan HT. A Monte Carlo investigation of artifacts caused by liver uptake in single-photon emission computed tomography perfusion imaging with technetium 99m-labeled agents. J Nucl Cardiol. 1996 Jan-Feb; 3(1):18-29.